Jill K Schinkel1, Stephanie Shao2, Shelia H Zahm3, Katherine A McGlynn3, Craig D Shriver4, Kangmin Zhu5. 1. John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, United States. 2. John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, United States; Uniformed Services University of the Health Sciences, Bethesda, MD, United States. 3. National Cancer Institute, NIH, Rockville, MD, United States. 4. John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, United States; General Surgery Service, Walter Reed National Military Medical Center, Bethesda, MD, United States; Uniformed Services University of the Health Sciences, Bethesda, MD, United States. 5. John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, United States; Uniformed Services University of the Health Sciences, Bethesda, MD, United States. Electronic address: kzhu@murthacancercenter.org.
Abstract
BACKGROUND: While the incidence of bladder cancer is twice as high among whites than among blacks, mortality is higher among blacks than whites. Unequal access to medical care may be an important factor. Insufficient access to care could delay cancer detection and treatment, which can result in worse survival. The purpose of this study was to evaluate whether survival differed between black and white bladder cancer patients in the Department of Defense (DoD), which provides universal healthcare to all beneficiaries regardless of racial background. METHODS: This study was based on data from the U.S. DoD Automated Central Tumor Registry (ACTUR). White and black patients histologically diagnosed with bladder cancer between 1990 and 2004 were included in the study and followed to the end of 2007. The outcomes were all-cause mortality and recurrence. We assessed the relationship between race and outcomes of interest using Cox proportional hazard ratios (HRs) for all, non-muscle invasive (NMIBC), and muscle invasive (MIBC) bladder cancers, separately. RESULTS: The survival of black and white individuals did not differ statistically. No significant racial differences in survival (HR: 0.96, 95% CI: 0.76-1.22) or recurrence-free survival (HR: 0.94, 95% CI: 0.69-1.30) were observed after adjustment for demographic variables, tumor characteristics, and treatment. Similar findings were observed for NMIBC and MIBC patients, respectively. CONCLUSION: Black patients were more likely to present with MIBC than white patients. However, white and black patients with bladder cancer were not significantly different in overall and recurrence-free survival regardless of muscle invasion. Our study suggests the importance of equal access to healthcare in reducing racial disparities in bladder cancer survival.
BACKGROUND: While the incidence of bladder cancer is twice as high among whites than among blacks, mortality is higher among blacks than whites. Unequal access to medical care may be an important factor. Insufficient access to care could delay cancer detection and treatment, which can result in worse survival. The purpose of this study was to evaluate whether survival differed between black and white bladder cancerpatients in the Department of Defense (DoD), which provides universal healthcare to all beneficiaries regardless of racial background. METHODS: This study was based on data from the U.S. DoD Automated Central Tumor Registry (ACTUR). White and black patients histologically diagnosed with bladder cancer between 1990 and 2004 were included in the study and followed to the end of 2007. The outcomes were all-cause mortality and recurrence. We assessed the relationship between race and outcomes of interest using Cox proportional hazard ratios (HRs) for all, non-muscle invasive (NMIBC), and muscle invasive (MIBC) bladder cancers, separately. RESULTS: The survival of black and white individuals did not differ statistically. No significant racial differences in survival (HR: 0.96, 95% CI: 0.76-1.22) or recurrence-free survival (HR: 0.94, 95% CI: 0.69-1.30) were observed after adjustment for demographic variables, tumor characteristics, and treatment. Similar findings were observed for NMIBC and MIBCpatients, respectively. CONCLUSION: Black patients were more likely to present with MIBC than white patients. However, white and black patients with bladder cancer were not significantly different in overall and recurrence-free survival regardless of muscle invasion. Our study suggests the importance of equal access to healthcare in reducing racial disparities in bladder cancer survival.
Authors: M Craig Hall; Sam S Chang; Guido Dalbagni; Raj Som Pruthi; John Derek Seigne; Eila Curlee Skinner; J Stuart Wolf; Paul F Schellhammer Journal: J Urol Date: 2007-12 Impact factor: 7.450
Authors: Matthew E Nielsen; Angela B Smith; Anne-Marie Meyer; Tzy-Mey Kuo; Seth Tyree; William Y Kim; Matthew I Milowsky; Raj S Pruthi; Robert C Millikan Journal: Cancer Date: 2013-10-10 Impact factor: 6.860
Authors: Apar Kishor Ganti; Shanmuga P Subbiah; Anne Kessinger; Wilson I Gonsalves; Peter T Silberstein; Fausto R Loberiza Journal: Clin Lung Cancer Date: 2013-11-14 Impact factor: 4.785
Authors: Karim Chamie; Mark S Litwin; Jeffrey C Bassett; Timothy J Daskivich; Julie Lai; Jan M Hanley; Badrinath R Konety; Christopher S Saigal Journal: Cancer Date: 2013-06-04 Impact factor: 6.860
Authors: George R Prout; Margaret N Wesley; Peter G McCarron; Vivien W Chen; Raymond S Greenberg; Robert M Mayberry; Brenda K Edwards Journal: Cancer Date: 2004-02-01 Impact factor: 6.860
Authors: J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif Journal: Eur Urol Date: 2013-12-12 Impact factor: 20.096
Authors: Nikhil V Kotha; Abhishek Kumar; Edmund M Qiao; Alex S Qian; Rohith S Voora; Vinit Nalawade; A Karim Kader; Rana R McKay; Tyler F Stewart; Brent S Rose Journal: J Natl Cancer Inst Date: 2022-04-11 Impact factor: 13.506
Authors: Hamideh Rashidian; Kazem Zendehdel; Rajabali Daroudi; Mohammad Reza Ebadzadeh; Ali Akbar Haghdoost Journal: Iran J Public Health Date: 2018-04 Impact factor: 1.429